Dec 03, 2021 / 05:00PM GMT
Jacob K. Johnson - Stephens Inc., Research Division - Analyst
Good morning, everybody, I'm Jacob Johnson, Life Science Tools and diagnostics analyst here at Stephens. Really pleased to be joined by Quintin Lai, Head of Corporate Development and Investor Relations at West. Quintin, thanks for joining us today. I'll turn it over to you for any introductory comments you want to make, and then we'll launch into Q&A.
Quintin J. Lai - West Pharmaceutical Services, Inc. - VP of Corporate Development, Strategy & IR
Well, Jacob, first on behalf of what we want to thank Stephens for hosting us here at the conference. It's great to be in person here and really impressed with how Stephens has set up the conference, and very much appreciate that.
Questions and Answers:
Jacob K. Johnson - Stephens Inc., Research Division - AnalystThank you for, Quintin. I know we need to talk COVID at some point, but I don't want to start there even with this variant. So let's talk non-COVID and the broader trends you're seeing
Trustpilot
